Dr Reddy's Laboratories Ltd. announced on Friday the launch of Regadenoson injection, used as an agent in the imaging of heart muscle to check blood flow, in the U.S. market.
Regadenoson injection is supplied as single-dose pre-filled syringes, 0.4 mg/5 ml (0.08 mg/ml). It is a generic therapeutic equivalent of Lexiscan injection, approved by the U.S. Food and Drug Administration (USFDA), Dr Reddy's said in a regulatory filing.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
The injection is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
In a separate filing, Dr Reddy's said it has issued a Form 483 with one observation by the U.S. FDA after a routine GMP inspection at its API manufacturing facility (CTO 1) in Bollaram, Hyderabad.
"The inspection was conducted from May 1, 2023, to May 5, 2023. We have been issued a Form 483 with one observation, which we will address within the stipulated timeline", the company said.
As per the U.S. FDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.